Human immunodeficiency virus-related polyneuropathy remains a painful condition resulting from damaged nerve endings.
Introduction
Vitamin deficiencies in HIV patients, strongly indicate a higher degree of disease progression [1] , adverse effects and high mortality during the initiation of combination antiretroviral treatment (CART) [2] [3] [4] . Polyneuropathy (PN) has probably emerged as the most prevalent neurologic adverse outcome associated with human immunodeficiency virus (HIV) infection [5] [6], CART [7] and serum vitamin concentration.
PN remains difficult to treat and causes significant functional impairment that negatively affects the patient's quality of life [8] . Its symptoms include distal symmetrical distribution, sensorimotor paralysis, paresthesia and pain in the hands and feet. The pathogenesis of PN is likely multifactorial [9] with known risk factors such as treatment with nucleoside analogues, other neurotoxic drugs, vitamin B-12 deficiency, alcohol abuse, and diabetes mellitus. The HIV protein (gp120), as well as host chemokine and cytokine responses, may trigger a multifaceted interaction that leads to PN [6] .
Prior to CART, the prevalence of PN was approximately 14% among outpatients. It ranged from 2% -35% depending on whether patients had early HIV disease or in the hospital [10] [11] . About 11% -43% of CART naive individuals in most resource-limited settings present PN [12] [13] [14] [15] . The use of dideoxynucleoside reverse transcriptase inhibitors (dNRTIs) increases the risk of neurotoxicity [7] . As viral gp120 or HIV-associated chronic immune dysregulation may directly sensitise peripheral sensory nerves, dNRTI-induced mitochondrial toxicity could exacerbate the condition. Stavudine (d4T) is a notable dNRTIs that has strongly been associated with mitochondrial toxicity. Adverse effects associated with mitochondrial toxicity such as PN and lipodystrophy led to the discontinuation of d4T [16] . However, due to low cost and limited alternatives, d4T is still used resource-limited settings [17] .
Chronic immune activation characterised by increased generation of free reactive oxygen species (ROS) and perturbation of antioxidant defence system has been shown to occur in HIV-infected patients [18] [19] [20] . This creates an oxidative stress (OS) which is instability between oxidants and antioxidants. This state damages both structure and function of key tissues [21] . As a cofactor, OS may enhance disease pathogenesis through increased viral replication, inflammatory responses and sensitivity to ARV-drugs [21] . Therefore, OS resulting from CART may be far much beyond levels of that caused by HIV disease itself. It is also associated with PN and can increase the body's demand for certain antioxidants such as vitamins.
Deficiencies in body micronutrients occur due to reduced intake of micronu-trients caused by to HIV infection associated anorexia, excessive micronutrient loss through the stool, malabsorption, increased metabolic demand, body redistribution and parasitic infections [22] [23] [24] . Vitamin deficiency in HIV-infected individuals may be high as a result of the abnormality [25] [26] [27] [28] .
That explains the reason behind recommended daily doses of vitamin supplements as a measure of preventing PN before CART initiation. When a patient reports symptoms of PN during CART clinicians prescribe vitamin supplements as a way of treating this disorder.
In resource-limited settings, the HIV-infected population heavily rely on over the counter minerals, vitamins, phytotherapeutic preparations and alternative medicines without any substantiated scientific evidence to support their use [29] .
Most patients feign ignorance when it comes to high intakes of vitamin products available to them [30] [31].
Biochemical Functions of Vitamins
The body needs several nutrients including flavoproteins and cytochromes for normal functioning of the mitochondria [32] . Micronutrient deficiencies predispose HIV-infected individuals to mitochondrial toxicity, a condition that leads to oxidative stress (OS). The impairment of the antioxidant defence system during OS involves an imbalance in redox status, which can cause a deficiency in micronutrients and contribute to disease progression. These reactions are linked to cellular apoptosis, PN and decreased immune proliferation [19] [20] [21] . The redox imbalance cover changes in glutathione (GSH), thioredoxin (TRX), superoxide dismutase (SOD), ascorbic acid, glutathione peroxidase (GPx), tocopherol (TOC) and selenium (Se).
Vitamins act as co-enzymes in the breakdown of food for energy production [33] [34] [35] . Deficiencies in vitamin A, B-1, B-2, B-6, B-12, and E can impair host resistance and lymphocyte function [34] . Vitamin A deficiency leads to impaired neutrophil function and reductions in lymphocyte response. The reduction in cell-mediated immune response may result from lack of vitamin C. Low vitamin E levels may cause interference in both proliferation and functions of T-cells [36] [37] . Antioxidants reduce the damage caused by OS [34] . Due to interrelated functions, thiamine, riboflavin, pyridoxine, cobalamin, niacin pantothenic acid, biotin and folic acid are available as a single formulation of vitamin B complex [38] . The focus of this paper is on vitamins that have been associated with PN. They include vitamin B-1, B-6, B-12 and E (Table 1).
Vitamin B-1 (Thiamine)
Thiamine exists in five forms namely, thiamine monophosphate (ThMP), thiamine diphosphate (ThDP), also called thiamine pyrophosphate (TPP), thiamine triphosphate (ThTP), adenosine thiamine triphosphate (AThTP), and adenosine thiamine diphosphate (AThDP). The best-characterized form is TPP, a coenzyme in the catabolism of sugars and amino acids. Thiamine participates in thedecarboxylation of alpha-keto acids, branched-chain amino acids during energy Coenzymes that catalyse gluconeogenesis, synthesis of neurotransmitters, heme, nucleic acids, conversion of homocysteine to cysteine, production of lymphocytes and IL-2 PN, irritability, confusion, seizures in severe deficiency.
Inflammation of the tongue, sores or ulcers of the mouth, angular stomatitis and anaemia. generation, biosynthesis of the neurotransmitter acetylcholine and gammaaminobutyric acid (GABA).
There are no reports of adverse effects associated with excessive consumption of thiamine [39] . Deficiency in thiamine from various sources [40] 
Vitamin B-6 (Pyridoxine)
Three forms of vitamin B-6 pyridoxine, pyridoxal and pyridoxamine are enzymatically interconvertible. The human body converts pyridoxine into pyridoxal phosphate (PLP) which is an essential co-factor in the removal of acarboxyl group, sulphurdioxide, anamino group and amino transfer. The phosphorylation of pyridoxine to PLP is via ATP-dependent pyridoxal phosphokinase. PLP and pyridoxal are the main circulating forms found in most animal tissues [26] . Vi- Although vitamin B-6 deficiency occurs among HIV-infected, it also occurs in patients treated with isoniazid, phenelzine, hydralazine, and penicillamine [43] .
Among other things, deficiency of vitamin B-6 causes neurological effects such as seizures and convulsions. There is evidence that in HIV-infected people, lack of vitamin B-6 impairs the immune cell functions, through the reduction of lymphocyte maturation and diminished antibody production [45] .
Vitamin B-12 (Cobalamin)
Cobalamin participates in the formation of methionine by methylation of homocysteine [43] . The resultant byproduct tetrahydrofolate is useful in synthesising purine and pyrimidine. In addition, the formation of myelin sheath depends on cobalamin's participation in the conversion of l-methylmalonyl coenzyme A into succinyl coenzyme A.
The classical neurological effects of vitamin B-12 deficiency include sub-acute combined degeneration, neuropsychiatric symptoms, PN and optic neuropathy.
The most common cause of cobalamin deficiency is pernicious anaemia, a condition more common in African-Americans and Northern Europeans [43] .
Vitamin E (Alpha-Tocopherol)
Vitamin E consists of similar chromanol structures; trimethyl (a-), dimethyl (bor g-), and monomethyl (d-) tocopherol, and the corresponding tocotrienols [46] . The most abundant form of vitamin E in human beings is alpha-Tocopherol. Vitamin E inhibits lipid peroxidation in cell membranes and prevents OS.
The transfer of vitamin E to very low-density lipoproteins (VLDL) takes place via alpha-tocopherol transfer protein (TTP) [26] [47].
Since adipose tissues naturally contain alpha-tocopherol, its deficiency may take years to detect. Specifically, lack of vitamin E impairs T cell-mediated function, lymphocyte proliferation [48] and the principal pathological features include PN [27] .
Lows and Highs of Vitamin Supplements for HIV-Infected Patients
As Renwick [44] proposed that very low intakes of micronutrients would present adverse effects, which would decrease in severity with an increase in intake, and that severity of toxicity at high intakes will increase with dosage ( Figure 1 ).
That implies, safe usage of vitamin supplements in food insecure settings requires careful consideration of previous studies on large doses of micronutrients [49] , the upper tolerable levels (ULs) of intakes and potential adverse effects. The highest level of consumption where the risk of toxicity is equivalent to zero as defined by UL (Figure 1 ) [44] . To demonstrate meeting the need for a nutrient, the EAR characterizes the intake level of a nutrient at which the need of 50% of the population in that age group and gender. Lastly, recommended daily allow- High UL of 1000 mg per day of vitamin E have been established, however, due findings from meta-analyses the RDA remains 15 -20 mg per day of alpha-to copherol [55] . From the same meta-analyses, low-dose intakes of 150 mg per day proved beneficial. However, high intakes can indeed cause harm. Vitamin E may damage cells by acting as a pro-oxidant, hence causing oxidation [56] .
Unlike deficiencies, vitamin toxicities in HIV-infected patients in many resource-poor settings are scarce. The available data is inconsistent, scanty and largely based on individuals who are not HIV-infected. The data do not clearly support vitamin toxicity as a problem to be cautious about in HIV-infected persons. This, therefore, suggests that even with HIV-related PN, vitamin toxicity resulting from high intakes of supplements is less likely to be significant.
Effects of HIV-Infection on Vitamin Levels
Through malabsorption and rapid nutrient utilisation, HIV infection directly leads to the decline in CD4 cells and micronutrient levels ( Figure 2 ) [57] [58]. In turn, the level of essential nutrients like vitamin E is affected [59] . HIV-infection has also been associated with increased basal metabolic rate, increased energy expenditure and protein catabolism [60] . Further, the reduction in serum concentration of vitamins B6, B12 and E usually associated with low CD4 cells [56] [61], increases both OS and vitamin A, C and E uptake [62] [63].
Effect of CART on Vitamin Levels
Patients who use current classes of CART drugs that include reverse transcriptase inhibitors (NRTIs) or non-nucleoside reverse transcriptase inhibitors (NNRTIs) [64] [65], may experience lactic acidosis, hepatic steatosis (fatty liver), lipodystrophy and PN [66] . Metabolic adverse effects directly or indirectly affect the serum level of micronutrients. NRTIs cause mitochondrial damage, which not only leads to perturbation in the structure of mitochondria but also depletion of mitochondria. Accumulation of damaged mitochondria (mitochondrial toxicity) can reduce the absorption or increase the losses of several nutrients through vomiting and diarrhea [67] . Mitochondrial toxicity may also increase the production of ROS hence increasing the demand for antioxidant micronutrients. That explains why vitamin supplementation of lost vitamins reduces some complications related to the use CART.
The use of zidovudine (ZDV) was associated with low serum concentration of vitamin B-12 [68] [69] . Clinicians prescribe vitamin B-12 for treatment of ZDVassociated haematological toxicity and anaemia, which affects approximately 5% -10% of HIV-infected patients [68] [69]. Vitamin B-1 and vitaminB-2 which play a key role in the normal functioning of mitochondria, have both been found to diminish the effect of NRTI-associated lactic acidosis [70] [71] . CART related abnormal fat distribution, dyslipidemia and insulin resistance resulting from ROS can be minimised by vitamin E intakes [72] . Patients using a combination of 10 micronutrients reported a significant reduction in theincidence of PN [73] .
Genetic Predisposition
Susceptibility to PN varies among HIV-infected persons, with prevalence rates reported to range from 10% -35% [74] . The variability suggests a role for human genomic variation, though with much focus on mitochondrial DNA (mtDNA) variations. A number of mitochondrial haplogroups have been associated increased risk of mitochondrial dysfunction. People with European descent belonging to mitochondrial haplogroup T showed a marginally higher incidence of NRTI-associated neuropathy [75] . Hulgan and colleagues performed a mitochondrial haplogroup T demonstration in a CART exposed Caucasian casecontrol cohort. From their findings, about 17% of individuals who developed PN had mtDNA haplogroup T compared to 7% who did not develop PN [75] . African mtDNA generally have greater variation than that of Caucasians and thus difficult to classify. There exist limited association studies on African mtDNA variation. A single study on a non-Hispanic, African American cohort, identified mtDNA sub-haplogroup L1c as an independent predictor of PN [76] . Since the causes of PN are multifactorial, it is important to examine other genetic variations, which may explain susceptibility to PN, especially those affecting serum vitamin concentrations.
Evidence show that the amount of vitamin B and homocysteine circulating in the blood is genetically determined [77] . The 677T←C (rs1801133) polymor- duced by a phenotype of the 677T variant [78] . Individuals with such phenotype have higher homocysteine concentration, lower genomic DNA methylation [79] and may experience vitamin deficiency [80] . The concentration of vitamin B and homocysteine associates with other genetic variations, although results remain inconsistent [81] .
Mutations in the alkaline phosphatase (ALP) gene characterised by the low or complete absence of ALP activity, manifest as hypophosphatasia. This is an accumulation of phosphorous compounds including vitamin B-6 [82] . The concentration of vitamin B-6 was associated with the top signal namely rs1780324 polymorphism found within the ALP gene region [83] . In the presence of allele C, polymorphism, rs4654748 has most significantly been associated with vitamin B-6 deficiency. One study suggested that ALP mediates the association between two ALP gene SNPs (rs4654748 and rs1780324) with vitamin B-6 [83] . Since ALP enzyme plays a role in clearing vitamin B-6, lower vitamin B-6 levels in C allele carriers' could result from efficient clearance of vitamin B-6.
Studies have associated deficiency in vitamin B-12 with the overgrowth of Helicobacter pylori [84] . The H-antigens participate in mediating adhesion of H. pylori to gut mucosa.The fucosyltransferase 2 (FUT2) gene determines the human secretor (Se) blood group through α1, 2-fucosyltransferase phenotype expression. FUT mediates the fucosylation of oligosaccharides to form H-type 1 and 2 antigens [85] . Researchers have mapped rs6022662 SNP to exon 2 of the Vitamin E has been shown to have an immunomodulatory effect, which in part is mediated via its effects on the production of interleukin (IL)-1β, tumour necrosis factor (TNF)-α, and IL-6 [90] . SNPs located in IL-1β, IL-6 and TNF-α genes have been associated with cytokine production [91] . Genotypes AA and A/G located at TNF-α-308G > A were reported in subjects treated with vitamin E and had lower TNF-α production than placebo. In a genome-wide association study of circulating α-tocopherol, Major ). In total, the three SNPs represent 3.4% of the residual variance that may be associated with the serum concentration of α-tocopherol during vitamin E supplementation.
Conclusion
In conclusion, the diagnosis of PN heavily relies on clinical symptoms in many resource-limited settings. To manage this condition clinicians prescribe vitamin supplements because they are easy and inexpensive adjunctive therapy for improving HIV medication outcome. However, since there is poor screening of risk factors of PN and that patients can easily get affordable vitamins over the counter, the development of PN remains a big burden in these settings. Although the benefits of vitamin supplements in CART naive individuals are well established, there need for studies focusing on how SNPs could influence levels of vitamins in HIV-infected patients receiving CART. As the HIV care rapidly advances towards personalised therapy, the application of micronutrient associated commonly, distributed SNPs among ethnic groups in resource-poor settings would greatly improve long-term treatment outcomes of HIV-infected persons.
